142 results
424B5
GTBP
GT Biopharma Inc
23 May 24
Prospectus supplement for primary offering
6:04am
expected financial performance and condition, operating results, our business strategy and our financing plans. The forward-looking statements … , commercialization, and marketing capabilities and strategy;
our intellectual property position, including the scope of protection we are able to establish
8-K
GTBP
GT Biopharma Inc
23 May 24
GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:02am
business strategy and our financing plans. The forward-looking statements in this prospectus supplement are not based on historical facts, but rather reflect … parties to conduct additional clinical trials of our product candidates; our manufacturing, commercialization, and marketing capabilities and strategy
8-K
5kwtc26v jqoi8l4a3us
22 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:55pm